Recent research came up with a new blood biomarker that has a high accuracy of predicting the spread of prostate cancer to other parts of the body through the lymph nodes. Such spreading of cancer cells are usually not detected by conventional imaging methods like CT scans. This new blood test measures the level of endoglin, a plasma biomarker which was also studied to predict the spread of colon and breast cancer.
The levels of endoglin in the blood were associated with increased risk of cancer cells spreading to the lymph nodes. Each 1ng/mL increase of plasma endoglin increases the risk of cancer spread by 17 percent.
No comments:
Post a Comment
Please add your free comment!